Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York AOD 9604 (Lipotropin) Las Vegas Sky Health Wellness Clinic AOD9604 5mg Research Peptide Perth Western Australia Perth BioTech Perth's trusted source for precision research peptides. The anti obesity drug AOD 9604 is banned by WADA and ASADA in a blow to Essendon's defence